(C83.2) Смешанная мелко- и крупноклеточная (диффузная)

More details coming soon

Icon
3 114 017 in individuals diagnosis смешанная мелко- и крупноклеточная (диффузная) confirmed
Icon
213 135 deaths with diagnosis смешанная мелко- и крупноклеточная (диффузная)
Icon
7% mortality rate associated with the disease смешанная мелко- и крупноклеточная (диффузная)

Diagnosis смешанная мелко- и крупноклеточная (диффузная) is diagnosed Men are 11.42% more likely than Women

1 734 759

Men receive the diagnosis смешанная мелко- и крупноклеточная (диффузная)

107 180 (6.2 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 379 258

Women receive the diagnosis смешанная мелко- и крупноклеточная (диффузная)

105 955 (7.7 %)

Died from this diagnosis.

Risk Group for the Disease смешанная мелко- и крупноклеточная (диффузная) - Men and Women aged 65-69

Icon
In Men diagnosis is most often set at age 0-95+
Icon
Less common in men the disease occurs at Age 0-1Less common in women the disease occurs at Age 0-1
Icon
In Women diagnosis is most often set at age 0-95+

Disease Features смешанная мелко- и крупноклеточная (диффузная)

Icon
Absence or low individual and public risk
Icon

Смешанная мелко- и крупноклеточная (диффузная) - what does this mean

Mixed small and large cell (diffuse) lung cancer is a type of cancer that occurs when abnormal cells in the lungs grow and divide uncontrollably, forming a malignant tumor. these abnormal cells can spread to other parts of the body and can be difficult to treat.

What happens during the disease - смешанная мелко- и крупноклеточная (диффузная)

The pathogenesis of mixed small and large cell (diffuse) disease is complex and multifactorial. it is thought to be caused by an abnormal immune response to environmental factors such as viruses, bacteria, or chemicals, resulting in an uncontrolled proliferation of both small and large cells. this uncontrolled proliferation results in increased production of inflammatory cytokines and other mediators, which can lead to tissue damage and organ dysfunction.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Биохимический анализ крови
  • Биохимический анализ мочи
  • Общий анализ крови
  • Анализ на антитела
  • Рентгенография
  • Компьютерная томография
  • Ультразвуковое исследование
  • Бактериологическое исследование
  • Проба по флюорографии
  • Исследование мочи на экссудаты
  • Исследование на вирус иммунодефицита человека

Treatment and Medical Assistance

Main goal: To reduce symptoms and improve quality of life for those with mixed small- and large-cell (diffuse) disease.
  • Prescribe medications to reduce symptoms and improve quality of life.
  • Provide lifestyle advice on diet, exercise, and stress management.
  • Refer patient to a specialist for further evaluation and treatment.
  • Monitor patient's condition and adjust medications as needed.
  • Perform regular physical examinations to assess the progression of the disease.
  • Provide emotional support and guidance to help patient cope with the disease.
  • Educate patient and family on the disease and available treatments.
  • Refer patient for counseling or support groups if needed.
  • Perform imaging tests such as X-rays or CT scans to monitor the disease.
  • Recommend alternative therapies such as acupuncture, massage, or yoga.
Icon
14 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Смешанная мелко- и крупноклеточная (диффузная) - Prevention

The best way to prevent mixed small and large cell (diffuse) disease is to avoid exposure to known risk factors, such as smoking, exposure to radiation, and certain chemicals. additionally, it is important to maintain a healthy lifestyle, including eating a balanced diet and getting regular exercise. vaccines may also be available to protect against certain types of the disease.